Ledger.Open graph →
SEC Form D · Amendment · filed September 14, 2020

DalCor Pharmaceuticals US, LLC

Offering
$3.9M
Sold
$3.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Sarasota, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

D. Michael Dixon · Sarasota, FLDirectorDonald Black · Sarasota, FLDirectorPaul Fonteyne · Sarasota, FLDirectorSoul Ventures Management Peter Ltd · New York, NYDirectorJason Reese · Palm Beach Gardens, FLDirectorNeil Chatfield · North Ryde, Channel IslandsDirectorKathleen M. Conlon · North Ryde, Channel IslandsDirectorPaul Fonteyne · Sarasota, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗